APA (7th ed.) Citation

AL, R., S, T., D, B., JW, G., H, G., C, S., & R, A. (2023). Evaluating the Utility of a New Pathogenicity Predictor for Pediatric Cardiomyopathy. Human mutation, 2023, 8892833. https://doi.org/10.1155/2023/8892833

Chicago Style (17th ed.) Citation

AL, Rippert, Trackman S, Burstein D, Gaynor JW, Griffis H, Seymour C, and Ahrens-Nicklas R. "Evaluating the Utility of a New Pathogenicity Predictor for Pediatric Cardiomyopathy." Human Mutation 2023 (2023): 8892833. https://doi.org/10.1155/2023/8892833.

MLA (9th ed.) Citation

AL, Rippert, et al. "Evaluating the Utility of a New Pathogenicity Predictor for Pediatric Cardiomyopathy." Human Mutation, vol. 2023, 2023, p. 8892833, https://doi.org/10.1155/2023/8892833.